<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02613364</url>
  </required_header>
  <id_info>
    <org_study_id>URCC14040</org_study_id>
    <secondary_id>NCI-2015-01144</secondary_id>
    <secondary_id>RSRB052271</secondary_id>
    <secondary_id>URCC14040</secondary_id>
    <secondary_id>URCC-14040</secondary_id>
    <secondary_id>URCC-14040</secondary_id>
    <secondary_id>R01CA181064</secondary_id>
    <secondary_id>UG1CA189961</secondary_id>
    <nct_id>NCT02613364</nct_id>
  </id_info>
  <brief_title>Yoga, Survivorship Health Education, and Cognitive Behavioral Therapy in Reducing Insomnia in Cancer Survivors</brief_title>
  <acronym>YOCAS-II</acronym>
  <official_title>A Randomized Clinical Trial Comparing the Effectiveness of Yoga, Survivorship Health Education, and Cognitive Behavioral Therapy for Treating Insomnia in Cancer Survivors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Rochester NCORP Research Base</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Rochester</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized phase III trial compares yoga, survivorship health education program, and&#xD;
      cognitive behavioral therapy in reducing sleep disturbance (insomnia) in cancer survivors.&#xD;
      Insomnia can be described as excessive daytime napping, difficulty falling asleep, difficulty&#xD;
      staying asleep, or waking up earlier than desired. Insomnia can increase fatigue, impair&#xD;
      physical function, impair immune function, cause circadian rhythms (known as the biological&#xD;
      clock) to be disrupted and decrease quality of life. Yoga may improve circadian rhythms,&#xD;
      physical and immune function, and improve insomnia and sleep quality in cancer survivors. It&#xD;
      is not yet known whether yoga is more effective at treating insomnia than a health education&#xD;
      program or cognitive behavioral therapy program.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PRIMARY OBJECTIVES:&#xD;
&#xD;
      I. To determine if Yoga for Cancer Survivors (YOCAS) is effective for improving&#xD;
      patient-reported insomnia (Insomnia Severity Index) compared to Cognitive Behavioral Therapy&#xD;
      for Insomnia (CBT-I) and a health education control immediately post intervention.&#xD;
&#xD;
      SECONDARY OBJECTIVES:&#xD;
&#xD;
      I. To examine if YOCAS is effective for improving objective symptoms of insomnia (sleep&#xD;
      latency, sleep efficiency, wake after sleep onset, sleep duration, and daytime napping via&#xD;
      actigraphy) and global sleep quality impairment (Pittsburgh Sleep Quality Index) compared to&#xD;
      CBT-I and a health education control.&#xD;
&#xD;
      II. To examine if YOCAS and CBT-I are effective for maintaining improvements in insomnia&#xD;
      (Insomnia Severity Index) 3 and 6 months post intervention compared to a health education&#xD;
      control.&#xD;
&#xD;
      OUTLINE: Patients are randomized to 1 of 3 arms.&#xD;
&#xD;
      ARM I: Patients undergo the YOCAS intervention comprising 18 specific physical postures and&#xD;
      mindfulness exercises focused on breathing and meditation and meet with the yoga instructor&#xD;
      over 75 minutes 2 times a week for 4 weeks.&#xD;
&#xD;
      ARM II: Patients undergo CBT-I intervention comprising sleep education, sleep hygiene, sleep&#xD;
      restriction, stimulus control, cognitive therapy, and relapse prevention delivered by a&#xD;
      health professional over 90 minutes once a week for 8 weeks.&#xD;
&#xD;
      ARM III: Patients attend survivorship health education sessions over 75 minutes 2 times a&#xD;
      week for 4 weeks based on the American Society of Clinical Oncology cancer survivorship&#xD;
      educational recommendations delivered by a community health educator. Patients also receive a&#xD;
      booklet entitled, &quot;Cancer Survivorship Next Steps for Patients and Their Families.&quot;&#xD;
&#xD;
      After completion of intervention, patients are followed up at 3 and 6 months.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 6, 2016</start_date>
  <completion_date type="Actual">February 4, 2020</completion_date>
  <primary_completion_date type="Actual">February 4, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean Change in the ISI Comparing YOCAS vs. CBT-I</measure>
    <time_frame>Baseline up to post intervention (approximately 4 to 8 weeks)</time_frame>
    <description>The Insomnia Severity Index is a validated measure of insomnia. A 5-point Likert scale of 7 questions is used to rate each item (e.g., 0 = no problem; 4 = very severe problem), yielding a total score ranging from 0 to 28 with higher scores indicating higher severity of insomnia. Means and 95% confidence intervals for YOCAS and CBT-I will be calculated and plotted and examined in comparison with the a priori specified non-inferiority margin of 1.15.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean Change in the ISI Comparing YOCAS vs. Health Education</measure>
    <time_frame>Baseline up to post intervention (approximately 4 to 8 weeks)</time_frame>
    <description>The Insomnia Severity Index is a validated measure of insomnia. A 5-point Likert scale of 7 questions is used to rate each item (e.g., 0 = no problem; 4 = very severe problem), yielding a total score ranging from 0 to 28 with higher scores indicating higher severity of insomnia. A linear mixed effects ANCOVA will be used to assess the statistical significance of the differences in mean change between YOCAS and health education.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean Change in Global Sleep Quality Impairment as Measured by the Pittsburgh Sleep Quality Inventory (PSQI) Total Score Comparing YOCAS vs. Health Education</measure>
    <time_frame>Baseline up to post intervention (approximately 4 to 8 weeks)</time_frame>
    <description>The PSQI measures sleep quality with a total score ranging from 0-21 with higher scores indicating worse sleep quality. A linear mixed effects ANCOVA will be used to assess the statistical significance of the differences in mean change between YOCAS and health education.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Change in Global Sleep Quality Impairment as Measured by the Pittsburgh Sleep Quality Inventory (PSQI) Total Score Comparing YOCAS vs. CBT-I.</measure>
    <time_frame>Baseline up to post intervention (approximately 4 to 8 weeks)</time_frame>
    <description>The PSQI measures sleep quality with a total score ranging from 0-21 with higher scores indicating worse sleep quality. A linear mixed effects ANCOVA will be used to assess the statistical significance of the differences in mean change between YOCAS and CBT-I.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Change in Objective Symptoms of Insomnia- Sleep Duration Via Actigraphy Comparing YOCAS vs. Health Education</measure>
    <time_frame>Baseline up to post intervention (approximately 4 to 8 weeks)</time_frame>
    <description>Actigraphy will measure the number of minutes of actual sleep. A linear mixed effects ANCOVA will be used to assess the statistical significance of the differences in mean change between YOCAS and health education.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Change in Objective Symptoms of Insomnia- Sleep Duration Via Actigraphy Comparing YOCAS vs. CBT-I</measure>
    <time_frame>Baseline up to post intervention (approximately 4 to 8 weeks)</time_frame>
    <description>Actigraphy will measure the number of minutes of actual sleep. A linear mixed effects ANCOVA will be used to assess the statistical significance of the differences in mean change between YOCAS and CBT-I.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Change in Objective Symptoms of Insomnia- Wake After Sleep Onset Via Actigraphy Comparing YOCAS vs. Health Education</measure>
    <time_frame>Baseline up to post intervention (approximately 4 to 8 weeks)</time_frame>
    <description>Actigraphy will measure total minutes of wake time after sleep onset. A linear mixed effects ANCOVA will be used to assess the statistical significance of the differences in mean change between YOCAS and health education. The transformation of the log base 10 of the original measurement was used for the analysis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Change in Objective Symptoms of Insomnia- Wake After Sleep Onset Via Actigraphy Comparing YOCAS vs. CBT-I</measure>
    <time_frame>Baseline up to post intervention (approximately 4 to 8 weeks)</time_frame>
    <description>Actigraphy will measure total minutes of wake time after sleep onset. A linear mixed effects ANCOVA will be used to assess the statistical significance of the differences in mean change between YOCAS and CBT-I. The transformation of log base 10 of the original measurement was used for the analysis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Change in Objective Symptoms of Insomnia- Sleep Efficiency Via Actigraphy Comparing YOCAS vs. Health Education</measure>
    <time_frame>Baseline up to post intervention (approximately 4 to 8 weeks)</time_frame>
    <description>Actigraphy will measure the percent of time actually slept compared to intended time sleeping. A linear mixed effects ANCOVA will be used to assess the statistical significance of the differences in mean change between YOCAS and health education.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Change in Objective Symptoms of Insomnia- Sleep Efficiency Via Actigraphy Comparing YOCAS vs. CBT-I</measure>
    <time_frame>Baseline up to post intervention (approximately 4 to 8 weeks)</time_frame>
    <description>Actigraphy will measure the percent of time actually slept compared to intended time sleeping. A linear mixed effects ANCOVA will be used to assess the statistical significance of the differences in mean change between YOCAS and CBT-I.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Change in Objective Symptoms of Insomnia- Sleep Latency Via Actigraphy Comparing YOCAS vs. Health Education</measure>
    <time_frame>Baseline up to post intervention (approximately 4 to 8 weeks)</time_frame>
    <description>Actigraphy will measure the minutes it takes for the participant to fall asleep. A linear mixed effects ANCOVA will be used to assess the statistical significance of the differences in mean change between YOCAS and health education. The transformation of log base 10 of the (measurement + 1) was used in the analysis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Change in Objective Symptoms of Insomnia- Sleep Latency Via Actigraphy Comparing YOCAS vs. CBT-I</measure>
    <time_frame>Baseline up to post intervention (approximately 4 to 8 weeks)</time_frame>
    <description>Actigraphy will measure the minutes it takes for the participant to fall asleep. A linear mixed effects ANCOVA will be used to assess the statistical significance of the differences in mean change between YOCAS and CBT-I. The transformation of the log base 10 of the (measure + 1) was used in the analysis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Change in the ISI Comparing YOCAS and Health Education (3 Month)</measure>
    <time_frame>Baseline to 3 months</time_frame>
    <description>The Insomnia Severity Index is a validated measure of insomnia. A 5-point Likert scale of 7 questions is used to rate each item (e.g., 0 = no problem; 4 = very severe problem), yielding a total score ranging from 0 to 28 with higher scores indicating higher severity of insomnia. A linear mixed effects ANCOVA will be used to assess the statistical significance of the differences in mean change between YOCAS and health education.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Change in the ISI Comparing YOCAS and CBT-I (3 Month)</measure>
    <time_frame>Baseline to 3 months</time_frame>
    <description>The Insomnia Severity Index is a validated measure of insomnia. A 5-point Likert scale of 7 questions is used to rate each item (e.g., 0 = no problem; 4 = very severe problem), yielding a total score ranging from 0 to 28 with higher scores indicating higher severity of insomnia. A linear mixed effects ANCOVA will be used to assess the statistical significance of the differences in mean change between YOCAS and CBT-I.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Change in the ISI Comparing YOCAS and Health Education (6 Month)</measure>
    <time_frame>Baseline to 6 months</time_frame>
    <description>The Insomnia Severity Index is a validated measure of insomnia. A 5-point Likert scale of 7 questions is used to rate each item (e.g., 0 = no problem; 4 = very severe problem), yielding a total score ranging from 0 to 28 with higher scores indicating higher severity of insomnia. A linear mixed effects ANCOVA will be used to assess the statistical significance of the differences in mean change between YOCAS and health education.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Change in the ISI Comparing YOCAS and CBT-I (6 Month)</measure>
    <time_frame>Baseline to 6 months</time_frame>
    <description>The Insomnia Severity Index is a validated measure of insomnia. A 5-point Likert scale of 7 questions is used to rate each item (e.g., 0 = no problem; 4 = very severe problem), yielding a total score ranging from 0 to 28 with higher scores indicating higher severity of insomnia. A linear mixed effects ANCOVA will be used to assess the statistical significance of the differences in mean change between YOCAS and CBT-I.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">746</enrollment>
  <condition>Cancer Survivor</condition>
  <condition>Insomnia</condition>
  <condition>Malignant Neoplasm</condition>
  <arm_group>
    <arm_group_label>Arm I (behavioral intervention-yoga)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients undergo the YOCAS intervention comprising 18 specific physical postures and mindfulness exercises focused on breathing and meditation and meet with the yoga instructor over 75 minutes 2 times a week for 4 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm II (cognitive intervention-CBT-I)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients undergo CBT-I intervention comprising sleep education, sleep hygiene, sleep restriction, stimulus control, cognitive therapy, and relapse prevention delivered by a health professional over 90 minutes once a week for 8 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm III (educational intervention)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients attend survivorship health education sessions over 75 minutes 2 times a week for 4 weeks based on the American Society of Clinical Oncology cancer survivorship educational recommendations delivered by a community health educator. Patients also receive a booklet entitled, &quot;Cancer Survivorship Next Steps for Patients and Their Families.&quot;</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Behavioral Intervention</intervention_name>
    <description>Undergo yoga intervention</description>
    <arm_group_label>Arm I (behavioral intervention-yoga)</arm_group_label>
    <other_name>Behavior Conditioning Therapy</other_name>
    <other_name>Behavior Modification</other_name>
    <other_name>Behavior or Life Style Modifications</other_name>
    <other_name>Behavior Therapy</other_name>
    <other_name>Behavioral Interventions</other_name>
    <other_name>Behavioral Modification</other_name>
    <other_name>BEHAVIORAL THERAPY</other_name>
    <other_name>Behavioral Treatment</other_name>
    <other_name>Behavioral Treatments</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cognitive Intervention</intervention_name>
    <description>Undergo CBT-I intervention</description>
    <arm_group_label>Arm II (cognitive intervention-CBT-I)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Educational Intervention</intervention_name>
    <description>Receive health education</description>
    <arm_group_label>Arm III (educational intervention)</arm_group_label>
    <other_name>Education for Intervention</other_name>
    <other_name>Intervention by Education</other_name>
    <other_name>Intervention through Education</other_name>
    <other_name>Intervention, Educational</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Laboratory Biomarker Analysis</intervention_name>
    <description>Correlative studies</description>
    <arm_group_label>Arm I (behavioral intervention-yoga)</arm_group_label>
    <arm_group_label>Arm II (cognitive intervention-CBT-I)</arm_group_label>
    <arm_group_label>Arm III (educational intervention)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Monitoring Device</intervention_name>
    <description>Correlative studies</description>
    <arm_group_label>Arm I (behavioral intervention-yoga)</arm_group_label>
    <arm_group_label>Arm II (cognitive intervention-CBT-I)</arm_group_label>
    <arm_group_label>Arm III (educational intervention)</arm_group_label>
    <other_name>Monitor</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Quality-of-Life Assessment</intervention_name>
    <description>Ancillary studies</description>
    <arm_group_label>Arm I (behavioral intervention-yoga)</arm_group_label>
    <arm_group_label>Arm II (cognitive intervention-CBT-I)</arm_group_label>
    <arm_group_label>Arm III (educational intervention)</arm_group_label>
    <other_name>Quality of Life Assessment</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Have a confirmed diagnosis of cancer&#xD;
&#xD;
          -  Have received surgery, chemotherapy, and/or radiation therapy&#xD;
&#xD;
          -  Have completed all surgery, chemotherapy and/or radiation therapy within the last 2-60&#xD;
             months&#xD;
&#xD;
          -  Meet Diagnostic and Statistical Manual of Mental Disorders (DSM)-V criteria for&#xD;
             insomnia and score &gt;= 10 on the Insomnia Severity Index&#xD;
&#xD;
          -  Be able to read and understand English&#xD;
&#xD;
          -  Be able to provide written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Have contraindications to functional testing or yoga participation according to the&#xD;
             treating physician&#xD;
&#xD;
          -  Have practiced yoga &gt;= 1 day a week within the 3 months prior to enrolling in the&#xD;
             study&#xD;
&#xD;
          -  Be planning to start yoga on their own during the time they are enrolled in the study&#xD;
&#xD;
          -  Have a confirmed diagnosis of sleep apnea or restless leg syndrome&#xD;
&#xD;
          -  Be receiving any form of treatment for cancer with the exception of hormonal or&#xD;
             biologic therapy&#xD;
&#xD;
          -  Have distant metastases&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karen Mustian</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Rochester NCORP Research Base</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hawaii MU NCORP</name>
      <address>
        <city>Honolulu</city>
        <state>Hawaii</state>
        <zip>96813</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Heartland NCORP</name>
      <address>
        <city>Decatur</city>
        <state>Illinois</state>
        <zip>62526</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wichita NCORP</name>
      <address>
        <city>Wichita</city>
        <state>Kansas</state>
        <zip>67214</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gulf South MU-NCORP</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70112</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Michigan Cancer Research Consortium NCORP</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cancer Research Consortium of West Michigan</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49503</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Metro-Minnesota NCORP</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55426</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nevada Cancer Research Foundation NCORP</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Rochester NCORP Research Base</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14642</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Southeast Clinical Oncology Research Consortium</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Columbus NCORP</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dayton Clinical Oncology Program</name>
      <address>
        <city>Dayton</city>
        <state>Ohio</state>
        <zip>45420</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pacific Cancer Research Consortium Ncorp</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Greenville Health System NCORP</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29605</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wisconsin NCORP</name>
      <address>
        <city>Marshfield</city>
        <state>Wisconsin</state>
        <zip>54449</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aurora NCORP</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>November 20, 2015</study_first_submitted>
  <study_first_submitted_qc>November 23, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 24, 2015</study_first_posted>
  <results_first_submitted>February 4, 2021</results_first_submitted>
  <results_first_submitted_qc>February 27, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">March 23, 2021</results_first_posted>
  <last_update_submitted>February 27, 2021</last_update_submitted>
  <last_update_submitted_qc>February 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Rochester NCORP Research Base</investigator_affiliation>
    <investigator_full_name>Karen Mustian</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Sleep Initiation and Maintenance Disorders</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>June 7, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/64/NCT02613364/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>6 participants were registered but not eligible.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Arm I (Behavioral Intervention-yoga)</title>
          <description>Patients undergo the YOCAS intervention comprising 18 specific physical postures and mindfulness exercises focused on breathing and meditation and meet with the yoga instructor over 75 minutes 2 times a week for 4 weeks.&#xD;
Behavioral Intervention: Undergo yoga intervention&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
        </group>
        <group group_id="P2">
          <title>Arm II (Cognitive Intervention-CBT-I)</title>
          <description>Patients undergo CBT-I intervention comprising sleep education, sleep hygiene, sleep restriction, stimulus control, cognitive therapy, and relapse prevention delivered by a health professional over 90 minutes once a week for 8 weeks.&#xD;
Cognitive Intervention: Undergo CBT-I intervention&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
        </group>
        <group group_id="P3">
          <title>Arm III (Educational Intervention)</title>
          <description>Patients attend survivorship health education sessions over 75 minutes 2 times a week for 4 weeks based on the American Society of Clinical Oncology cancer survivorship educational recommendations delivered by a community health educator. Patients also receive a booklet entitled, &quot;Cancer Survivorship Next Steps for Patients and Their Families.&quot;&#xD;
Educational Intervention: Receive health education&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="251"/>
                <participants group_id="P2" count="238"/>
                <participants group_id="P3" count="251"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="185"/>
                <participants group_id="P2" count="148"/>
                <participants group_id="P3" count="175"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="66"/>
                <participants group_id="P2" count="90"/>
                <participants group_id="P3" count="76"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Other</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
                <participants group_id="P2" count="29"/>
                <participants group_id="P3" count="17"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Too time consuming</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
                <participants group_id="P2" count="26"/>
                <participants group_id="P3" count="26"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
                <participants group_id="P2" count="18"/>
                <participants group_id="P3" count="17"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Medical</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="13"/>
                <participants group_id="P3" count="9"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Disliked Study Procedure</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Disliked Intervention</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Arm I (Behavioral Intervention-yoga)</title>
          <description>Patients undergo the YOCAS intervention comprising 18 specific physical postures and mindfulness exercises focused on breathing and meditation and meet with the yoga instructor over 75 minutes 2 times a week for 4 weeks.&#xD;
Behavioral Intervention: Undergo yoga intervention&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
        </group>
        <group group_id="B2">
          <title>Arm II (Cognitive Intervention-CBT-I)</title>
          <description>Patients undergo CBT-I intervention comprising sleep education, sleep hygiene, sleep restriction, stimulus control, cognitive therapy, and relapse prevention delivered by a health professional over 90 minutes once a week for 8 weeks.&#xD;
Cognitive Intervention: Undergo CBT-I intervention&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
        </group>
        <group group_id="B3">
          <title>Arm III (Educational Intervention)</title>
          <description>Patients attend survivorship health education sessions over 75 minutes 2 times a week for 4 weeks based on the American Society of Clinical Oncology cancer survivorship educational recommendations delivered by a community health educator. Patients also receive a booklet entitled, &quot;Cancer Survivorship Next Steps for Patients and Their Families.&quot;&#xD;
Educational Intervention: Receive health education&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="251"/>
            <count group_id="B2" value="238"/>
            <count group_id="B3" value="251"/>
            <count group_id="B4" value="740"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="251"/>
                    <count group_id="B2" value="238"/>
                    <count group_id="B3" value="251"/>
                    <count group_id="B4" value="740"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="55" lower_limit="24" upper_limit="85"/>
                    <measurement group_id="B2" value="56" lower_limit="24" upper_limit="83"/>
                    <measurement group_id="B3" value="57" lower_limit="28" upper_limit="80"/>
                    <measurement group_id="B4" value="56" lower_limit="24" upper_limit="85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="251"/>
                    <count group_id="B2" value="238"/>
                    <count group_id="B3" value="251"/>
                    <count group_id="B4" value="740"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="234"/>
                    <measurement group_id="B2" value="216"/>
                    <measurement group_id="B3" value="236"/>
                    <measurement group_id="B4" value="686"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="15"/>
                    <measurement group_id="B4" value="54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="251"/>
                    <count group_id="B2" value="238"/>
                    <count group_id="B3" value="251"/>
                    <count group_id="B4" value="740"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="11"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="29"/>
                    <measurement group_id="B2" value="26"/>
                    <measurement group_id="B3" value="28"/>
                    <measurement group_id="B4" value="83"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="213"/>
                    <measurement group_id="B2" value="207"/>
                    <measurement group_id="B3" value="214"/>
                    <measurement group_id="B4" value="634"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="251"/>
                    <count group_id="B2" value="238"/>
                    <count group_id="B3" value="251"/>
                    <count group_id="B4" value="740"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="251"/>
                    <measurement group_id="B2" value="238"/>
                    <measurement group_id="B3" value="251"/>
                    <measurement group_id="B4" value="740"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>ISI at Baseline</title>
          <description>The Insomnia Severity Index is a validated measure of insomnia. A 5-point Likert scale of 7 questions is used to rate each item (e.g., 0 = no problem; 4 = very severe problem), yielding a total score ranging from 0 to 28 with higher scores indicating higher severity of insomnia.</description>
          <population>The difference between the number of participants analyzed and the overall number of baseline participants is due to participant withdrawal.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="216"/>
                    <count group_id="B2" value="198"/>
                    <count group_id="B3" value="205"/>
                    <count group_id="B4" value="619"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15.41" spread="4.34"/>
                    <measurement group_id="B2" value="15.57" spread="4.35"/>
                    <measurement group_id="B3" value="15.39" spread="4.39"/>
                    <measurement group_id="B4" value="15.45" spread="4.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Mean Change in the ISI Comparing YOCAS vs. CBT-I</title>
        <description>The Insomnia Severity Index is a validated measure of insomnia. A 5-point Likert scale of 7 questions is used to rate each item (e.g., 0 = no problem; 4 = very severe problem), yielding a total score ranging from 0 to 28 with higher scores indicating higher severity of insomnia. Means and 95% confidence intervals for YOCAS and CBT-I will be calculated and plotted and examined in comparison with the a priori specified non-inferiority margin of 1.15.</description>
        <time_frame>Baseline up to post intervention (approximately 4 to 8 weeks)</time_frame>
        <population>The overall number of participants analyzed is higher than the number of participants who completed the study because the timeframe for this outcome measure was from baseline up to post-intervention. Some participants withdrew after the post-intervention assessment.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm I (Behavioral Intervention-yoga)</title>
            <description>Patients undergo the YOCAS intervention comprising 18 specific physical postures and mindfulness exercises focused on breathing and meditation and meet with the yoga instructor over 75 minutes 2 times a week for 4 weeks.&#xD;
Behavioral Intervention: Undergo yoga intervention&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
          <group group_id="O2">
            <title>Arm II (Cognitive Intervention-CBT-I)</title>
            <description>Patients undergo CBT-I intervention comprising sleep education, sleep hygiene, sleep restriction, stimulus control, cognitive therapy, and relapse prevention delivered by a health professional over 90 minutes once a week for 8 weeks.&#xD;
Cognitive Intervention: Undergo CBT-I intervention&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
          <group group_id="O3">
            <title>Arm III (Educational Intervention)</title>
            <description>Patients attend survivorship health education sessions over 75 minutes 2 times a week for 4 weeks based on the American Society of Clinical Oncology cancer survivorship educational recommendations delivered by a community health educator. Patients also receive a booklet entitled, &quot;Cancer Survivorship Next Steps for Patients and Their Families.&quot;&#xD;
Educational Intervention: Receive health education&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Change in the ISI Comparing YOCAS vs. CBT-I</title>
          <description>The Insomnia Severity Index is a validated measure of insomnia. A 5-point Likert scale of 7 questions is used to rate each item (e.g., 0 = no problem; 4 = very severe problem), yielding a total score ranging from 0 to 28 with higher scores indicating higher severity of insomnia. Means and 95% confidence intervals for YOCAS and CBT-I will be calculated and plotted and examined in comparison with the a priori specified non-inferiority margin of 1.15.</description>
          <population>The overall number of participants analyzed is higher than the number of participants who completed the study because the timeframe for this outcome measure was from baseline up to post-intervention. Some participants withdrew after the post-intervention assessment.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="202"/>
                <count group_id="O2" value="163"/>
                <count group_id="O3" value="185"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.61" lower_limit="-4.19" upper_limit="-3.03"/>
                    <measurement group_id="O2" value="-7.22" lower_limit="-7.95" upper_limit="-6.49"/>
                    <measurement group_id="O3" value="-2.19" lower_limit="-2.84" upper_limit="-1.55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Constructed a 95% confidence interval on the mean change of ISI from baseline between the arms (YOCAS - CBT-I). If the lower bound of the interval is less than 1.5 then we conclude that YOCAS is non-inferior.</groups_desc>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority is established if the difference in mean change on the ISI between YOCAS and CBT-I is less than 1.15. Using ANCOVA to estimate differences in mean change between YOCAS and CBT-I, a correlation of 0.576 (from our prior study), and a sample of 168 subjects per group, we will have sufficient (80%) power to detect non-inferiority using a margin of 1.15 at p = 0.025.</non_inferiority_desc>
            <p_value>&lt;.0001</p_value>
            <p_value_desc>The p-value shown above is from the Least Squares Mean between YOCAS - CBT-I from the Mixed Model.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>3.52</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.43</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>2.66</ci_lower_limit>
            <ci_upper_limit>4.37</ci_upper_limit>
            <estimate_desc>The comparison is YOCAS - CBT-I</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Mean Change in the ISI Comparing YOCAS vs. Health Education</title>
        <description>The Insomnia Severity Index is a validated measure of insomnia. A 5-point Likert scale of 7 questions is used to rate each item (e.g., 0 = no problem; 4 = very severe problem), yielding a total score ranging from 0 to 28 with higher scores indicating higher severity of insomnia. A linear mixed effects ANCOVA will be used to assess the statistical significance of the differences in mean change between YOCAS and health education.</description>
        <time_frame>Baseline up to post intervention (approximately 4 to 8 weeks)</time_frame>
        <population>The overall number of participants analyzed is higher than the number of participants who completed the study because the timeframe for this outcome measure was from baseline up to post-intervention. Some participants withdrew after the post-intervention assessment.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm I (Behavioral Intervention-yoga)</title>
            <description>Patients undergo the YOCAS intervention comprising 18 specific physical postures and mindfulness exercises focused on breathing and meditation and meet with the yoga instructor over 75 minutes 2 times a week for 4 weeks.&#xD;
Behavioral Intervention: Undergo yoga intervention&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
          <group group_id="O2">
            <title>Arm II (Cognitive Intervention-CBT-I)</title>
            <description>Patients undergo CBT-I intervention comprising sleep education, sleep hygiene, sleep restriction, stimulus control, cognitive therapy, and relapse prevention delivered by a health professional over 90 minutes once a week for 8 weeks.&#xD;
Cognitive Intervention: Undergo CBT-I intervention&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
          <group group_id="O3">
            <title>Arm III (Educational Intervention)</title>
            <description>Patients attend survivorship health education sessions over 75 minutes 2 times a week for 4 weeks based on the American Society of Clinical Oncology cancer survivorship educational recommendations delivered by a community health educator. Patients also receive a booklet entitled, &quot;Cancer Survivorship Next Steps for Patients and Their Families.&quot;&#xD;
Educational Intervention: Receive health education&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Change in the ISI Comparing YOCAS vs. Health Education</title>
          <description>The Insomnia Severity Index is a validated measure of insomnia. A 5-point Likert scale of 7 questions is used to rate each item (e.g., 0 = no problem; 4 = very severe problem), yielding a total score ranging from 0 to 28 with higher scores indicating higher severity of insomnia. A linear mixed effects ANCOVA will be used to assess the statistical significance of the differences in mean change between YOCAS and health education.</description>
          <population>The overall number of participants analyzed is higher than the number of participants who completed the study because the timeframe for this outcome measure was from baseline up to post-intervention. Some participants withdrew after the post-intervention assessment.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="202"/>
                <count group_id="O2" value="163"/>
                <count group_id="O3" value="185"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.61" lower_limit="-4.19" upper_limit="-3.03"/>
                    <measurement group_id="O2" value="-7.22" lower_limit="-7.95" upper_limit="-6.49"/>
                    <measurement group_id="O3" value="-2.19" lower_limit="-2.84" upper_limit="-1.55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>The comparison of YOCAS to the health education control is a traditional null hypothesis of no difference with a two-sided alpha.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Using ANCOVA to estimate differences in mean change between YOCAS and health education, a correlation of 0.576 (from our prior study), and a sample size of 168 evaluable subjects per group, we will have sufficient power to detect differences on the ISI of at least 1.3, 1.5 and 1.6 (all larger than our 1.15 non-inferiority margin) at 80%, 90%, and 95% power, respectively</non_inferiority_desc>
            <p_value>0.0009</p_value>
            <p_value_desc>the comparison of YOCAS to the health education control is a traditional null hypothesis of no difference with a two-sided alpha. The p-value shown is from the Least Squares Mean (YOCAS - Health Education) generated from the Mixed Model.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-1.40</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.42</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-2.23</ci_lower_limit>
            <ci_upper_limit>-0.58</ci_upper_limit>
            <estimate_desc>The comparison is from the ISI Least Squares Mean difference (YOCAS - Health Education) generated from the Mixed Model.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Change in Global Sleep Quality Impairment as Measured by the Pittsburgh Sleep Quality Inventory (PSQI) Total Score Comparing YOCAS vs. Health Education</title>
        <description>The PSQI measures sleep quality with a total score ranging from 0-21 with higher scores indicating worse sleep quality. A linear mixed effects ANCOVA will be used to assess the statistical significance of the differences in mean change between YOCAS and health education.</description>
        <time_frame>Baseline up to post intervention (approximately 4 to 8 weeks)</time_frame>
        <population>The overall number of participants analyzed is higher than the number of participants who completed the study because the timeframe for this outcome measure was from baseline up to post-intervention. Some participants withdrew after the post-intervention assessment.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm I (Behavioral Intervention-yoga)</title>
            <description>Patients undergo the YOCAS intervention comprising 18 specific physical postures and mindfulness exercises focused on breathing and meditation and meet with the yoga instructor over 75 minutes 2 times a week for 4 weeks.&#xD;
Behavioral Intervention: Undergo yoga intervention&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
          <group group_id="O2">
            <title>Arm II (Cognitive Intervention-CBT-I)</title>
            <description>Patients undergo CBT-I intervention comprising sleep education, sleep hygiene, sleep restriction, stimulus control, cognitive therapy, and relapse prevention delivered by a health professional over 90 minutes once a week for 8 weeks.&#xD;
Cognitive Intervention: Undergo CBT-I intervention&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
          <group group_id="O3">
            <title>Arm III (Educational Intervention)</title>
            <description>Patients attend survivorship health education sessions over 75 minutes 2 times a week for 4 weeks based on the American Society of Clinical Oncology cancer survivorship educational recommendations delivered by a community health educator. Patients also receive a booklet entitled, &quot;Cancer Survivorship Next Steps for Patients and Their Families.&quot;&#xD;
Educational Intervention: Receive health education&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Change in Global Sleep Quality Impairment as Measured by the Pittsburgh Sleep Quality Inventory (PSQI) Total Score Comparing YOCAS vs. Health Education</title>
          <description>The PSQI measures sleep quality with a total score ranging from 0-21 with higher scores indicating worse sleep quality. A linear mixed effects ANCOVA will be used to assess the statistical significance of the differences in mean change between YOCAS and health education.</description>
          <population>The overall number of participants analyzed is higher than the number of participants who completed the study because the timeframe for this outcome measure was from baseline up to post-intervention. Some participants withdrew after the post-intervention assessment.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="202"/>
                <count group_id="O2" value="163"/>
                <count group_id="O3" value="186"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.59" lower_limit="-1.99" upper_limit="-1.18"/>
                    <measurement group_id="O2" value="-3.82" lower_limit="-4.30" upper_limit="-3.33"/>
                    <measurement group_id="O3" value="-1.11" lower_limit="-1.55" upper_limit="-0.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>The comparison of YOCAS to the health education control is a traditional null hypothesis of no difference with a two-sided alpha.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>The null hypothesis is that the mean change in the outcome measure between the two arms is zero.</non_inferiority_desc>
            <p_value>0.0700</p_value>
            <p_value_desc>The comparison of YOCAS to the health education control is a traditional null hypothesis of no difference with a two-sided alpha. The p-value shown is from the Least Squares Mean (YOCAS - Health Education) generated from the Mixed Model.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.47</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.26</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.98</ci_lower_limit>
            <ci_upper_limit>0.04</ci_upper_limit>
            <estimate_desc>The comparison is from the ISI Least Squares Mean difference (YOCAS - Health Education) generated from the Mixed Model.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Change in Global Sleep Quality Impairment as Measured by the Pittsburgh Sleep Quality Inventory (PSQI) Total Score Comparing YOCAS vs. CBT-I.</title>
        <description>The PSQI measures sleep quality with a total score ranging from 0-21 with higher scores indicating worse sleep quality. A linear mixed effects ANCOVA will be used to assess the statistical significance of the differences in mean change between YOCAS and CBT-I.</description>
        <time_frame>Baseline up to post intervention (approximately 4 to 8 weeks)</time_frame>
        <population>The overall number of participants analyzed is higher than the number of participants who completed the study because the timeframe for this outcome measure was from baseline up to post-intervention. Some participants withdrew after the post-intervention assessment.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm I (Behavioral Intervention-yoga)</title>
            <description>Patients undergo the YOCAS intervention comprising 18 specific physical postures and mindfulness exercises focused on breathing and meditation and meet with the yoga instructor over 75 minutes 2 times a week for 4 weeks.&#xD;
Behavioral Intervention: Undergo yoga intervention&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
          <group group_id="O2">
            <title>Arm II (Cognitive Intervention-CBT-I)</title>
            <description>Patients undergo CBT-I intervention comprising sleep education, sleep hygiene, sleep restriction, stimulus control, cognitive therapy, and relapse prevention delivered by a health professional over 90 minutes once a week for 8 weeks.&#xD;
Cognitive Intervention: Undergo CBT-I intervention&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
          <group group_id="O3">
            <title>Arm III (Educational Intervention)</title>
            <description>Patients attend survivorship health education sessions over 75 minutes 2 times a week for 4 weeks based on the American Society of Clinical Oncology cancer survivorship educational recommendations delivered by a community health educator. Patients also receive a booklet entitled, &quot;Cancer Survivorship Next Steps for Patients and Their Families.&quot;&#xD;
Educational Intervention: Receive health education&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Change in Global Sleep Quality Impairment as Measured by the Pittsburgh Sleep Quality Inventory (PSQI) Total Score Comparing YOCAS vs. CBT-I.</title>
          <description>The PSQI measures sleep quality with a total score ranging from 0-21 with higher scores indicating worse sleep quality. A linear mixed effects ANCOVA will be used to assess the statistical significance of the differences in mean change between YOCAS and CBT-I.</description>
          <population>The overall number of participants analyzed is higher than the number of participants who completed the study because the timeframe for this outcome measure was from baseline up to post-intervention. Some participants withdrew after the post-intervention assessment.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="202"/>
                <count group_id="O2" value="163"/>
                <count group_id="O3" value="186"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.59" lower_limit="-1.99" upper_limit="-1.18"/>
                    <measurement group_id="O2" value="-3.82" lower_limit="-4.30" upper_limit="-3.33"/>
                    <measurement group_id="O3" value="-1.11" lower_limit="-1.55" upper_limit="-0.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The comparison of YOCAS to CBT-I is a traditional null hypothesis of no difference with a two-sided alpha.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>The null hypothesis is that the mean change in the outcome measure between the two arms is zero.</non_inferiority_desc>
            <p_value>&lt;.0001</p_value>
            <p_value_desc>The comparison of YOCAS to CBT-I is a traditional null hypothesis of no difference with a two-sided alpha. The p-value shown is from the Least Squares Mean (YOCAS - CBT-I) generated from the Mixed Model.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>2.23</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.27</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.70</ci_lower_limit>
            <ci_upper_limit>2.75</ci_upper_limit>
            <estimate_desc>The comparison is from the ISI Least Squares Mean difference (YOCAS - CBT-I) generated from the Mixed Model.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Change in Objective Symptoms of Insomnia- Sleep Duration Via Actigraphy Comparing YOCAS vs. Health Education</title>
        <description>Actigraphy will measure the number of minutes of actual sleep. A linear mixed effects ANCOVA will be used to assess the statistical significance of the differences in mean change between YOCAS and health education.</description>
        <time_frame>Baseline up to post intervention (approximately 4 to 8 weeks)</time_frame>
        <population>The overall number of participants analyzed is lower than the number of participants who completed the study. This difference is due to the actigraphy device malfunction or battery issue and participant non-compliance.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm I (Behavioral Intervention-yoga)</title>
            <description>Patients undergo the YOCAS intervention comprising 18 specific physical postures and mindfulness exercises focused on breathing and meditation and meet with the yoga instructor over 75 minutes 2 times a week for 4 weeks.&#xD;
Behavioral Intervention: Undergo yoga intervention&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
          <group group_id="O2">
            <title>Arm II (Cognitive Intervention-CBT-I)</title>
            <description>Patients undergo CBT-I intervention comprising sleep education, sleep hygiene, sleep restriction, stimulus control, cognitive therapy, and relapse prevention delivered by a health professional over 90 minutes once a week for 8 weeks.&#xD;
Cognitive Intervention: Undergo CBT-I intervention&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
          <group group_id="O3">
            <title>Arm III (Educational Intervention)</title>
            <description>Patients attend survivorship health education sessions over 75 minutes 2 times a week for 4 weeks based on the American Society of Clinical Oncology cancer survivorship educational recommendations delivered by a community health educator. Patients also receive a booklet entitled, &quot;Cancer Survivorship Next Steps for Patients and Their Families.&quot;&#xD;
Educational Intervention: Receive health education&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Change in Objective Symptoms of Insomnia- Sleep Duration Via Actigraphy Comparing YOCAS vs. Health Education</title>
          <description>Actigraphy will measure the number of minutes of actual sleep. A linear mixed effects ANCOVA will be used to assess the statistical significance of the differences in mean change between YOCAS and health education.</description>
          <population>The overall number of participants analyzed is lower than the number of participants who completed the study. This difference is due to the actigraphy device malfunction or battery issue and participant non-compliance.</population>
          <units>minutes</units>
          <param>Least Squares Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="150"/>
                <count group_id="O2" value="135"/>
                <count group_id="O3" value="144"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="395.99" lower_limit="383.49" upper_limit="408.50"/>
                    <measurement group_id="O2" value="380.06" lower_limit="366.93" upper_limit="393.18"/>
                    <measurement group_id="O3" value="376.27" lower_limit="363.06" upper_limit="389.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>The comparison of YOCAS to the health education control is a traditional null hypothesis of no difference with a two-sided alpha.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>The null hypothesis is that the mean change in the outcome measure between the two arms is zero.</non_inferiority_desc>
            <p_value>0.0052</p_value>
            <p_value_desc>The comparison of YOCAS to the health education control is a traditional null hypothesis of no difference with a two-sided alpha. The p-value shown is from the Least Squares Mean (YOCAS - Health Education) generated from the Mixed Model.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>19.73</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>7.03</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>5.91</ci_lower_limit>
            <ci_upper_limit>33.54</ci_upper_limit>
            <estimate_desc>The comparison is from the Least Squares Mean difference (YOCAS - Health Education) generated from the Mixed Model.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Change in Objective Symptoms of Insomnia- Sleep Duration Via Actigraphy Comparing YOCAS vs. CBT-I</title>
        <description>Actigraphy will measure the number of minutes of actual sleep. A linear mixed effects ANCOVA will be used to assess the statistical significance of the differences in mean change between YOCAS and CBT-I.</description>
        <time_frame>Baseline up to post intervention (approximately 4 to 8 weeks)</time_frame>
        <population>The overall number of participants analyzed is lower than the number of participants who completed the study. This difference is due to the actigraphy device malfunction or battery issue and participant non-compliance.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm I (Behavioral Intervention-yoga)</title>
            <description>Patients undergo the YOCAS intervention comprising 18 specific physical postures and mindfulness exercises focused on breathing and meditation and meet with the yoga instructor over 75 minutes 2 times a week for 4 weeks.&#xD;
Behavioral Intervention: Undergo yoga intervention&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
          <group group_id="O2">
            <title>Arm II (Cognitive Intervention-CBT-I)</title>
            <description>Patients undergo CBT-I intervention comprising sleep education, sleep hygiene, sleep restriction, stimulus control, cognitive therapy, and relapse prevention delivered by a health professional over 90 minutes once a week for 8 weeks.&#xD;
Cognitive Intervention: Undergo CBT-I intervention&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
          <group group_id="O3">
            <title>Arm III (Educational Intervention)</title>
            <description>Patients attend survivorship health education sessions over 75 minutes 2 times a week for 4 weeks based on the American Society of Clinical Oncology cancer survivorship educational recommendations delivered by a community health educator. Patients also receive a booklet entitled, &quot;Cancer Survivorship Next Steps for Patients and Their Families.&quot;&#xD;
Educational Intervention: Receive health education&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Change in Objective Symptoms of Insomnia- Sleep Duration Via Actigraphy Comparing YOCAS vs. CBT-I</title>
          <description>Actigraphy will measure the number of minutes of actual sleep. A linear mixed effects ANCOVA will be used to assess the statistical significance of the differences in mean change between YOCAS and CBT-I.</description>
          <population>The overall number of participants analyzed is lower than the number of participants who completed the study. This difference is due to the actigraphy device malfunction or battery issue and participant non-compliance.</population>
          <units>minutes</units>
          <param>Least Squares Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="150"/>
                <count group_id="O2" value="135"/>
                <count group_id="O3" value="144"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="395.99" lower_limit="383.49" upper_limit="408.50"/>
                    <measurement group_id="O2" value="380.06" lower_limit="366.93" upper_limit="393.18"/>
                    <measurement group_id="O3" value="376.27" lower_limit="363.06" upper_limit="389.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>The null hypothesis is that the mean change in the outcome measure between the two arms is zero.</non_inferiority_desc>
            <p_value>0.0258</p_value>
            <p_value_desc>The comparison of YOCAS to CBT-I is a traditional null hypothesis of no difference with a two-sided alpha. The p-value shown is from the Least Squares Mean (YOCAS - CBT-I) generated from the Mixed Model.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>15.94</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>7.12</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.93</ci_lower_limit>
            <ci_upper_limit>29.94</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Change in Objective Symptoms of Insomnia- Wake After Sleep Onset Via Actigraphy Comparing YOCAS vs. Health Education</title>
        <description>Actigraphy will measure total minutes of wake time after sleep onset. A linear mixed effects ANCOVA will be used to assess the statistical significance of the differences in mean change between YOCAS and health education. The transformation of the log base 10 of the original measurement was used for the analysis.</description>
        <time_frame>Baseline up to post intervention (approximately 4 to 8 weeks)</time_frame>
        <population>The overall number of participants analyzed is lower than the number of participants who completed the study. This difference is due to the actigraphy device malfunction or battery issue and participant non-compliance.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm I (Behavioral Intervention-yoga)</title>
            <description>Patients undergo the YOCAS intervention comprising 18 specific physical postures and mindfulness exercises focused on breathing and meditation and meet with the yoga instructor over 75 minutes 2 times a week for 4 weeks.&#xD;
Behavioral Intervention: Undergo yoga intervention&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
          <group group_id="O2">
            <title>Arm II (Cognitive Intervention-CBT-I)</title>
            <description>Patients undergo CBT-I intervention comprising sleep education, sleep hygiene, sleep restriction, stimulus control, cognitive therapy, and relapse prevention delivered by a health professional over 90 minutes once a week for 8 weeks.&#xD;
Cognitive Intervention: Undergo CBT-I intervention&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
          <group group_id="O3">
            <title>Arm III (Educational Intervention)</title>
            <description>Patients attend survivorship health education sessions over 75 minutes 2 times a week for 4 weeks based on the American Society of Clinical Oncology cancer survivorship educational recommendations delivered by a community health educator. Patients also receive a booklet entitled, &quot;Cancer Survivorship Next Steps for Patients and Their Families.&quot;&#xD;
Educational Intervention: Receive health education&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Change in Objective Symptoms of Insomnia- Wake After Sleep Onset Via Actigraphy Comparing YOCAS vs. Health Education</title>
          <description>Actigraphy will measure total minutes of wake time after sleep onset. A linear mixed effects ANCOVA will be used to assess the statistical significance of the differences in mean change between YOCAS and health education. The transformation of the log base 10 of the original measurement was used for the analysis.</description>
          <population>The overall number of participants analyzed is lower than the number of participants who completed the study. This difference is due to the actigraphy device malfunction or battery issue and participant non-compliance.</population>
          <units>minutes</units>
          <param>Least Squares Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="150"/>
                <count group_id="O2" value="135"/>
                <count group_id="O3" value="144"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.85" lower_limit="1.81" upper_limit="1.89"/>
                    <measurement group_id="O2" value="1.81" lower_limit="1.76" upper_limit="1.85"/>
                    <measurement group_id="O3" value="1.86" lower_limit="1.81" upper_limit="1.90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>The null hypothesis is that the mean change in the outcome measure between the two arms is zero.</non_inferiority_desc>
            <p_value>0.92</p_value>
            <p_value_desc>The comparison of YOCAS to the health education control is a traditional null hypothesis of no difference with a two-sided alpha. The p-value shown is from the Least Squares Mean (YOCAS - Health Education) generated from the Mixed Model.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.002</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.025</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.053</ci_lower_limit>
            <ci_upper_limit>0.048</ci_upper_limit>
            <estimate_desc>The comparison is from the Least Squares Mean difference (YOCAS - Health Education) generated from the Mixed Model.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Change in Objective Symptoms of Insomnia- Wake After Sleep Onset Via Actigraphy Comparing YOCAS vs. CBT-I</title>
        <description>Actigraphy will measure total minutes of wake time after sleep onset. A linear mixed effects ANCOVA will be used to assess the statistical significance of the differences in mean change between YOCAS and CBT-I. The transformation of log base 10 of the original measurement was used for the analysis.</description>
        <time_frame>Baseline up to post intervention (approximately 4 to 8 weeks)</time_frame>
        <population>The overall number of participants analyzed is lower than the number of participants who completed the study. This difference is due to the actigraphy device malfunction or battery issue and participant non-compliance.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm I (Behavioral Intervention-yoga)</title>
            <description>Patients undergo the YOCAS intervention comprising 18 specific physical postures and mindfulness exercises focused on breathing and meditation and meet with the yoga instructor over 75 minutes 2 times a week for 4 weeks.&#xD;
Behavioral Intervention: Undergo yoga intervention&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
          <group group_id="O2">
            <title>Arm II (Cognitive Intervention-CBT-I)</title>
            <description>Patients undergo CBT-I intervention comprising sleep education, sleep hygiene, sleep restriction, stimulus control, cognitive therapy, and relapse prevention delivered by a health professional over 90 minutes once a week for 8 weeks.&#xD;
Cognitive Intervention: Undergo CBT-I intervention&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
          <group group_id="O3">
            <title>Arm III (Educational Intervention)</title>
            <description>Patients attend survivorship health education sessions over 75 minutes 2 times a week for 4 weeks based on the American Society of Clinical Oncology cancer survivorship educational recommendations delivered by a community health educator. Patients also receive a booklet entitled, &quot;Cancer Survivorship Next Steps for Patients and Their Families.&quot;&#xD;
Educational Intervention: Receive health education&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Change in Objective Symptoms of Insomnia- Wake After Sleep Onset Via Actigraphy Comparing YOCAS vs. CBT-I</title>
          <description>Actigraphy will measure total minutes of wake time after sleep onset. A linear mixed effects ANCOVA will be used to assess the statistical significance of the differences in mean change between YOCAS and CBT-I. The transformation of log base 10 of the original measurement was used for the analysis.</description>
          <population>The overall number of participants analyzed is lower than the number of participants who completed the study. This difference is due to the actigraphy device malfunction or battery issue and participant non-compliance.</population>
          <units>minutes</units>
          <param>Least Squares Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="150"/>
                <count group_id="O2" value="135"/>
                <count group_id="O3" value="144"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.85" lower_limit="1.81" upper_limit="1.89"/>
                    <measurement group_id="O2" value="1.81" lower_limit="1.76" upper_limit="1.85"/>
                    <measurement group_id="O3" value="1.86" lower_limit="1.81" upper_limit="1.90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The comparison of YOCAS to the CBT-I control is a traditional null hypothesis of no difference with a two-sided alpha.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>The null hypothesis is that the mean change in the outcome measure between the two arms is zero.</non_inferiority_desc>
            <p_value>0.07</p_value>
            <p_value_desc>The comparison of YOCAS to CBT-I is a traditional null hypothesis of no difference with a two-sided alpha. The p-value shown is from the Least Squares Mean (YOCAS - Health Education) generated from the Mixed Model.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.05</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.026</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.004</ci_lower_limit>
            <ci_upper_limit>0.098</ci_upper_limit>
            <estimate_desc>The comparison is from the Least Squares Mean difference (YOCAS - CBT-I) generated from the Mixed Model.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Change in Objective Symptoms of Insomnia- Sleep Efficiency Via Actigraphy Comparing YOCAS vs. Health Education</title>
        <description>Actigraphy will measure the percent of time actually slept compared to intended time sleeping. A linear mixed effects ANCOVA will be used to assess the statistical significance of the differences in mean change between YOCAS and health education.</description>
        <time_frame>Baseline up to post intervention (approximately 4 to 8 weeks)</time_frame>
        <population>The overall number of participants analyzed is lower than the number of participants who completed the study. This difference is due to the actigraphy device malfunction or battery issue and participant non-compliance.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm I (Behavioral Intervention-yoga)</title>
            <description>Patients undergo the YOCAS intervention comprising 18 specific physical postures and mindfulness exercises focused on breathing and meditation and meet with the yoga instructor over 75 minutes 2 times a week for 4 weeks.&#xD;
Behavioral Intervention: Undergo yoga intervention&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
          <group group_id="O2">
            <title>Arm II (Cognitive Intervention-CBT-I)</title>
            <description>Patients undergo CBT-I intervention comprising sleep education, sleep hygiene, sleep restriction, stimulus control, cognitive therapy, and relapse prevention delivered by a health professional over 90 minutes once a week for 8 weeks.&#xD;
Cognitive Intervention: Undergo CBT-I intervention&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
          <group group_id="O3">
            <title>Arm III (Educational Intervention)</title>
            <description>Patients attend survivorship health education sessions over 75 minutes 2 times a week for 4 weeks based on the American Society of Clinical Oncology cancer survivorship educational recommendations delivered by a community health educator. Patients also receive a booklet entitled, &quot;Cancer Survivorship Next Steps for Patients and Their Families.&quot;&#xD;
Educational Intervention: Receive health education&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Change in Objective Symptoms of Insomnia- Sleep Efficiency Via Actigraphy Comparing YOCAS vs. Health Education</title>
          <description>Actigraphy will measure the percent of time actually slept compared to intended time sleeping. A linear mixed effects ANCOVA will be used to assess the statistical significance of the differences in mean change between YOCAS and health education.</description>
          <population>The overall number of participants analyzed is lower than the number of participants who completed the study. This difference is due to the actigraphy device malfunction or battery issue and participant non-compliance.</population>
          <units>percent of time</units>
          <param>Least Squares Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="150"/>
                <count group_id="O2" value="135"/>
                <count group_id="O3" value="144"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="81.65" lower_limit="79.57" upper_limit="83.73"/>
                    <measurement group_id="O2" value="82.42" lower_limit="80.24" upper_limit="84.60"/>
                    <measurement group_id="O3" value="79.38" lower_limit="77.19" upper_limit="81.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>The comparison of YOCAS to the health education control is a traditional null hypothesis of no difference with a two-sided alpha.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>The null hypothesis is that the mean change in the outcome measure between the two arms is zero.</non_inferiority_desc>
            <p_value>0.04</p_value>
            <p_value_desc>The comparison of YOCAS to the health education control is a traditional null hypothesis of no difference with a two-sided alpha. The p-value shown is from the Least Squares Mean (YOCAS - Health Education) generated from the Mixed Model.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>2.27</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>1.11</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.09</ci_lower_limit>
            <ci_upper_limit>4.44</ci_upper_limit>
            <estimate_desc>The comparison is from the Least Squares Mean difference (YOCAS - Health Education) generated from the Mixed Model.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Change in Objective Symptoms of Insomnia- Sleep Efficiency Via Actigraphy Comparing YOCAS vs. CBT-I</title>
        <description>Actigraphy will measure the percent of time actually slept compared to intended time sleeping. A linear mixed effects ANCOVA will be used to assess the statistical significance of the differences in mean change between YOCAS and CBT-I.</description>
        <time_frame>Baseline up to post intervention (approximately 4 to 8 weeks)</time_frame>
        <population>The overall number of participants analyzed is lower than the number of participants who completed the study. This difference is due to the actigraphy device malfunction or battery issue and participant non-compliance.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm I (Behavioral Intervention-yoga)</title>
            <description>Patients undergo the YOCAS intervention comprising 18 specific physical postures and mindfulness exercises focused on breathing and meditation and meet with the yoga instructor over 75 minutes 2 times a week for 4 weeks.&#xD;
Behavioral Intervention: Undergo yoga intervention&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
          <group group_id="O2">
            <title>Arm II (Cognitive Intervention-CBT-I)</title>
            <description>Patients undergo CBT-I intervention comprising sleep education, sleep hygiene, sleep restriction, stimulus control, cognitive therapy, and relapse prevention delivered by a health professional over 90 minutes once a week for 8 weeks.&#xD;
Cognitive Intervention: Undergo CBT-I intervention&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
          <group group_id="O3">
            <title>Arm III (Educational Intervention)</title>
            <description>Patients attend survivorship health education sessions over 75 minutes 2 times a week for 4 weeks based on the American Society of Clinical Oncology cancer survivorship educational recommendations delivered by a community health educator. Patients also receive a booklet entitled, &quot;Cancer Survivorship Next Steps for Patients and Their Families.&quot;&#xD;
Educational Intervention: Receive health education&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Change in Objective Symptoms of Insomnia- Sleep Efficiency Via Actigraphy Comparing YOCAS vs. CBT-I</title>
          <description>Actigraphy will measure the percent of time actually slept compared to intended time sleeping. A linear mixed effects ANCOVA will be used to assess the statistical significance of the differences in mean change between YOCAS and CBT-I.</description>
          <population>The overall number of participants analyzed is lower than the number of participants who completed the study. This difference is due to the actigraphy device malfunction or battery issue and participant non-compliance.</population>
          <units>percent of time</units>
          <param>Least Squares Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="150"/>
                <count group_id="O2" value="135"/>
                <count group_id="O3" value="144"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="81.65" lower_limit="79.57" upper_limit="83.73"/>
                    <measurement group_id="O2" value="82.42" lower_limit="80.24" upper_limit="84.60"/>
                    <measurement group_id="O3" value="79.38" lower_limit="77.19" upper_limit="81.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The comparison of YOCAS to CBT-I is a traditional null hypothesis of no difference with a two-sided alpha.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>The null hypothesis is that the mean change in the outcome measure between the two arms is zero.</non_inferiority_desc>
            <p_value>0.49</p_value>
            <p_value_desc>The comparison of YOCAS to CBT-I is a traditional null hypothesis of no difference with a two-sided alpha. The p-value shown is from the Least Squares Mean (YOCAS - Health Education) generated from the Mixed Model.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.77</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>1.12</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-2.97</ci_lower_limit>
            <ci_upper_limit>1.43</ci_upper_limit>
            <estimate_desc>The comparison is from the Least Squares Mean difference (YOCAS - CBT-I) generated from the Mixed Model.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Change in Objective Symptoms of Insomnia- Sleep Latency Via Actigraphy Comparing YOCAS vs. Health Education</title>
        <description>Actigraphy will measure the minutes it takes for the participant to fall asleep. A linear mixed effects ANCOVA will be used to assess the statistical significance of the differences in mean change between YOCAS and health education. The transformation of log base 10 of the (measurement + 1) was used in the analysis.</description>
        <time_frame>Baseline up to post intervention (approximately 4 to 8 weeks)</time_frame>
        <population>The overall number of participants analyzed is lower than the number of participants who completed the study. This difference is due to the actigraphy device malfunction or battery issue and participant non-compliance.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm I (Behavioral Intervention-yoga)</title>
            <description>Patients undergo the YOCAS intervention comprising 18 specific physical postures and mindfulness exercises focused on breathing and meditation and meet with the yoga instructor over 75 minutes 2 times a week for 4 weeks.&#xD;
Behavioral Intervention: Undergo yoga intervention&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
          <group group_id="O2">
            <title>Arm II (Cognitive Intervention-CBT-I)</title>
            <description>Patients undergo CBT-I intervention comprising sleep education, sleep hygiene, sleep restriction, stimulus control, cognitive therapy, and relapse prevention delivered by a health professional over 90 minutes once a week for 8 weeks.&#xD;
Cognitive Intervention: Undergo CBT-I intervention&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
          <group group_id="O3">
            <title>Arm III (Educational Intervention)</title>
            <description>Patients attend survivorship health education sessions over 75 minutes 2 times a week for 4 weeks based on the American Society of Clinical Oncology cancer survivorship educational recommendations delivered by a community health educator. Patients also receive a booklet entitled, &quot;Cancer Survivorship Next Steps for Patients and Their Families.&quot;&#xD;
Educational Intervention: Receive health education&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Change in Objective Symptoms of Insomnia- Sleep Latency Via Actigraphy Comparing YOCAS vs. Health Education</title>
          <description>Actigraphy will measure the minutes it takes for the participant to fall asleep. A linear mixed effects ANCOVA will be used to assess the statistical significance of the differences in mean change between YOCAS and health education. The transformation of log base 10 of the (measurement + 1) was used in the analysis.</description>
          <population>The overall number of participants analyzed is lower than the number of participants who completed the study. This difference is due to the actigraphy device malfunction or battery issue and participant non-compliance.</population>
          <units>minutes</units>
          <param>Least Squares Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="150"/>
                <count group_id="O2" value="135"/>
                <count group_id="O3" value="144"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.76" lower_limit="0.69" upper_limit="0.83"/>
                    <measurement group_id="O2" value="0.74" lower_limit="0.67" upper_limit="0.82"/>
                    <measurement group_id="O3" value="0.80" lower_limit="0.73" upper_limit="0.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>The comparison of YOCAS to the health education control is a traditional null hypothesis of no difference with a two-sided alpha.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>The null hypothesis is that the mean change in the outcome measure between the two arms is zero.</non_inferiority_desc>
            <p_value>0.43</p_value>
            <p_value_desc>The comparison of YOCAS to the health education control is a traditional null hypothesis of no difference with a two-sided alpha. The p-value shown is from the Least Squares Mean (YOCAS - Health Education) generated from the Mixed Model.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.04</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.05</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.13</ci_lower_limit>
            <ci_upper_limit>0.05</ci_upper_limit>
            <estimate_desc>The comparison is from the Least Squares Mean difference (YOCAS - Health Education) generated from the Mixed Model.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Change in Objective Symptoms of Insomnia- Sleep Latency Via Actigraphy Comparing YOCAS vs. CBT-I</title>
        <description>Actigraphy will measure the minutes it takes for the participant to fall asleep. A linear mixed effects ANCOVA will be used to assess the statistical significance of the differences in mean change between YOCAS and CBT-I. The transformation of the log base 10 of the (measure + 1) was used in the analysis.</description>
        <time_frame>Baseline up to post intervention (approximately 4 to 8 weeks)</time_frame>
        <population>The overall number of participants analyzed is lower than the number of participants who completed the study. This difference is due to the actigraphy device malfunction or battery issue and participant non-compliance.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm I (Behavioral Intervention-yoga)</title>
            <description>Patients undergo the YOCAS intervention comprising 18 specific physical postures and mindfulness exercises focused on breathing and meditation and meet with the yoga instructor over 75 minutes 2 times a week for 4 weeks.&#xD;
Behavioral Intervention: Undergo yoga intervention&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
          <group group_id="O2">
            <title>Arm II (Cognitive Intervention-CBT-I)</title>
            <description>Patients undergo CBT-I intervention comprising sleep education, sleep hygiene, sleep restriction, stimulus control, cognitive therapy, and relapse prevention delivered by a health professional over 90 minutes once a week for 8 weeks.&#xD;
Cognitive Intervention: Undergo CBT-I intervention&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
          <group group_id="O3">
            <title>Arm III (Educational Intervention)</title>
            <description>Patients attend survivorship health education sessions over 75 minutes 2 times a week for 4 weeks based on the American Society of Clinical Oncology cancer survivorship educational recommendations delivered by a community health educator. Patients also receive a booklet entitled, &quot;Cancer Survivorship Next Steps for Patients and Their Families.&quot;&#xD;
Educational Intervention: Receive health education&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Change in Objective Symptoms of Insomnia- Sleep Latency Via Actigraphy Comparing YOCAS vs. CBT-I</title>
          <description>Actigraphy will measure the minutes it takes for the participant to fall asleep. A linear mixed effects ANCOVA will be used to assess the statistical significance of the differences in mean change between YOCAS and CBT-I. The transformation of the log base 10 of the (measure + 1) was used in the analysis.</description>
          <population>The overall number of participants analyzed is lower than the number of participants who completed the study. This difference is due to the actigraphy device malfunction or battery issue and participant non-compliance.</population>
          <units>minutes</units>
          <param>Least Squares Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="150"/>
                <count group_id="O2" value="135"/>
                <count group_id="O3" value="144"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.76" lower_limit="0.69" upper_limit="0.83"/>
                    <measurement group_id="O2" value="0.74" lower_limit="0.67" upper_limit="0.82"/>
                    <measurement group_id="O3" value="0.80" lower_limit="0.73" upper_limit="0.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The comparison of YOCAS to CBT-I is a traditional null hypothesis of no difference with a two-sided alpha.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>The null hypothesis is that the mean change in the outcome measure between the two arms is zero.</non_inferiority_desc>
            <p_value>0.70</p_value>
            <p_value_desc>The comparison of YOCAS to CBT-I is a traditional null hypothesis of no difference with a two-sided alpha. The p-value shown is from the Least Squares Mean (YOCAS - Health Education) generated from the Mixed Model.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.02</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.05</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.07</ci_lower_limit>
            <ci_upper_limit>0.11</ci_upper_limit>
            <estimate_desc>The comparison is from the Least Squares Mean difference (YOCAS - CBT-I) generated from the Mixed Model.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Change in the ISI Comparing YOCAS and Health Education (3 Month)</title>
        <description>The Insomnia Severity Index is a validated measure of insomnia. A 5-point Likert scale of 7 questions is used to rate each item (e.g., 0 = no problem; 4 = very severe problem), yielding a total score ranging from 0 to 28 with higher scores indicating higher severity of insomnia. A linear mixed effects ANCOVA will be used to assess the statistical significance of the differences in mean change between YOCAS and health education.</description>
        <time_frame>Baseline to 3 months</time_frame>
        <population>The overall number of participants analyzed in arms I &amp; II is higher than the number of participants who completed the study. This difference is due to some participants withdrew after this outcome measure was collected. The overall number of participants analyzed in arm III is lower than the number of participants who completed the study. This difference is due to participant non-compliance.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm I (Behavioral Intervention-yoga)</title>
            <description>Patients undergo the YOCAS intervention comprising 18 specific physical postures and mindfulness exercises focused on breathing and meditation and meet with the yoga instructor over 75 minutes 2 times a week for 4 weeks.&#xD;
Behavioral Intervention: Undergo yoga intervention&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
          <group group_id="O2">
            <title>Arm II (Cognitive Intervention-CBT-I)</title>
            <description>Patients undergo CBT-I intervention comprising sleep education, sleep hygiene, sleep restriction, stimulus control, cognitive therapy, and relapse prevention delivered by a health professional over 90 minutes once a week for 8 weeks.&#xD;
Cognitive Intervention: Undergo CBT-I intervention&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
          <group group_id="O3">
            <title>Arm III (Educational Intervention)</title>
            <description>Patients attend survivorship health education sessions over 75 minutes 2 times a week for 4 weeks based on the American Society of Clinical Oncology cancer survivorship educational recommendations delivered by a community health educator. Patients also receive a booklet entitled, &quot;Cancer Survivorship Next Steps for Patients and Their Families.&quot;&#xD;
Educational Intervention: Receive health education&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Change in the ISI Comparing YOCAS and Health Education (3 Month)</title>
          <description>The Insomnia Severity Index is a validated measure of insomnia. A 5-point Likert scale of 7 questions is used to rate each item (e.g., 0 = no problem; 4 = very severe problem), yielding a total score ranging from 0 to 28 with higher scores indicating higher severity of insomnia. A linear mixed effects ANCOVA will be used to assess the statistical significance of the differences in mean change between YOCAS and health education.</description>
          <population>The overall number of participants analyzed in arms I &amp; II is higher than the number of participants who completed the study. This difference is due to some participants withdrew after this outcome measure was collected. The overall number of participants analyzed in arm III is lower than the number of participants who completed the study. This difference is due to participant non-compliance.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="189"/>
                <count group_id="O2" value="153"/>
                <count group_id="O3" value="173"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.02" lower_limit="-5.72" upper_limit="-4.28"/>
                    <measurement group_id="O2" value="-7.59" lower_limit="-8.37" upper_limit="-6.81"/>
                    <measurement group_id="O3" value="-3.56" lower_limit="-4.31" upper_limit="-2.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>The comparison of YOCAS to the health education control is a traditional null hypothesis of no difference with a two-sided alpha.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>The null hypothesis is that the mean change in the outcome measure between the two arms is zero.</non_inferiority_desc>
            <p_value>0.0041</p_value>
            <p_value_desc>The comparison of YOCAS to the health education control is a traditional null hypothesis of no difference with a two-sided alpha. The p-value shown is from the Least Squares Mean (YOCAS - Health Education) generated from the Mixed Model.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-1.57</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.55</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-2.65</ci_lower_limit>
            <ci_upper_limit>-0.50</ci_upper_limit>
            <estimate_desc>The comparison is from the Least Squares Mean difference (YOCAS - Health Education) generated from the Mixed Model.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Change in the ISI Comparing YOCAS and CBT-I (3 Month)</title>
        <description>The Insomnia Severity Index is a validated measure of insomnia. A 5-point Likert scale of 7 questions is used to rate each item (e.g., 0 = no problem; 4 = very severe problem), yielding a total score ranging from 0 to 28 with higher scores indicating higher severity of insomnia. A linear mixed effects ANCOVA will be used to assess the statistical significance of the differences in mean change between YOCAS and CBT-I.</description>
        <time_frame>Baseline to 3 months</time_frame>
        <population>The overall number of participants analyzed in arms I &amp; II is higher than the number of participants who completed the study. This difference is due to some participants withdrew after this outcome measure was collected. The overall number of participants analyzed in arm III is lower than the number of participants who completed the study. This difference is due to participant non-compliance.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm I (Behavioral Intervention-yoga)</title>
            <description>Patients undergo the YOCAS intervention comprising 18 specific physical postures and mindfulness exercises focused on breathing and meditation and meet with the yoga instructor over 75 minutes 2 times a week for 4 weeks.&#xD;
Behavioral Intervention: Undergo yoga intervention&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
          <group group_id="O2">
            <title>Arm II (Cognitive Intervention-CBT-I)</title>
            <description>Patients undergo CBT-I intervention comprising sleep education, sleep hygiene, sleep restriction, stimulus control, cognitive therapy, and relapse prevention delivered by a health professional over 90 minutes once a week for 8 weeks.&#xD;
Cognitive Intervention: Undergo CBT-I intervention&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
          <group group_id="O3">
            <title>Arm III (Educational Intervention)</title>
            <description>Patients attend survivorship health education sessions over 75 minutes 2 times a week for 4 weeks based on the American Society of Clinical Oncology cancer survivorship educational recommendations delivered by a community health educator. Patients also receive a booklet entitled, &quot;Cancer Survivorship Next Steps for Patients and Their Families.&quot;&#xD;
Educational Intervention: Receive health education&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Change in the ISI Comparing YOCAS and CBT-I (3 Month)</title>
          <description>The Insomnia Severity Index is a validated measure of insomnia. A 5-point Likert scale of 7 questions is used to rate each item (e.g., 0 = no problem; 4 = very severe problem), yielding a total score ranging from 0 to 28 with higher scores indicating higher severity of insomnia. A linear mixed effects ANCOVA will be used to assess the statistical significance of the differences in mean change between YOCAS and CBT-I.</description>
          <population>The overall number of participants analyzed in arms I &amp; II is higher than the number of participants who completed the study. This difference is due to some participants withdrew after this outcome measure was collected. The overall number of participants analyzed in arm III is lower than the number of participants who completed the study. This difference is due to participant non-compliance.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="189"/>
                <count group_id="O2" value="153"/>
                <count group_id="O3" value="173"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.02" lower_limit="-5.72" upper_limit="-4.28"/>
                    <measurement group_id="O2" value="-7.59" lower_limit="-8.37" upper_limit="-6.81"/>
                    <measurement group_id="O3" value="-3.56" lower_limit="-4.31" upper_limit="-2.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The comparison of YOCAS to CBT-I is a traditional null hypothesis of no difference with a two-sided alpha.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>The null hypothesis is that the mean change in the outcome measure between the two arms is zero.</non_inferiority_desc>
            <p_value>&lt;.0001</p_value>
            <p_value_desc>The comparison of YOCAS to CBT-I is a traditional null hypothesis of no difference with a two-sided alpha. The p-value shown is from the Least Squares Mean (YOCAS - Health Education) generated from the Mixed Model.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>2.71</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.56</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.61</ci_lower_limit>
            <ci_upper_limit>3.81</ci_upper_limit>
            <estimate_desc>The comparison is from the Least Squares Mean difference (YOCAS - CBT-I) generated from the Mixed Model.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Change in the ISI Comparing YOCAS and Health Education (6 Month)</title>
        <description>The Insomnia Severity Index is a validated measure of insomnia. A 5-point Likert scale of 7 questions is used to rate each item (e.g., 0 = no problem; 4 = very severe problem), yielding a total score ranging from 0 to 28 with higher scores indicating higher severity of insomnia. A linear mixed effects ANCOVA will be used to assess the statistical significance of the differences in mean change between YOCAS and health education.</description>
        <time_frame>Baseline to 6 months</time_frame>
        <population>The overall number of participants analyzed is lower than the number of participants who completed the study. This difference is due to participant non-compliance.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm I (Behavioral Intervention-yoga)</title>
            <description>Patients undergo the YOCAS intervention comprising 18 specific physical postures and mindfulness exercises focused on breathing and meditation and meet with the yoga instructor over 75 minutes 2 times a week for 4 weeks.&#xD;
Behavioral Intervention: Undergo yoga intervention&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
          <group group_id="O2">
            <title>Arm II (Cognitive Intervention-CBT-I)</title>
            <description>Patients undergo CBT-I intervention comprising sleep education, sleep hygiene, sleep restriction, stimulus control, cognitive therapy, and relapse prevention delivered by a health professional over 90 minutes once a week for 8 weeks.&#xD;
Cognitive Intervention: Undergo CBT-I intervention&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
          <group group_id="O3">
            <title>Arm III (Educational Intervention)</title>
            <description>Patients attend survivorship health education sessions over 75 minutes 2 times a week for 4 weeks based on the American Society of Clinical Oncology cancer survivorship educational recommendations delivered by a community health educator. Patients also receive a booklet entitled, &quot;Cancer Survivorship Next Steps for Patients and Their Families.&quot;&#xD;
Educational Intervention: Receive health education&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Change in the ISI Comparing YOCAS and Health Education (6 Month)</title>
          <description>The Insomnia Severity Index is a validated measure of insomnia. A 5-point Likert scale of 7 questions is used to rate each item (e.g., 0 = no problem; 4 = very severe problem), yielding a total score ranging from 0 to 28 with higher scores indicating higher severity of insomnia. A linear mixed effects ANCOVA will be used to assess the statistical significance of the differences in mean change between YOCAS and health education.</description>
          <population>The overall number of participants analyzed is lower than the number of participants who completed the study. This difference is due to participant non-compliance.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="182"/>
                <count group_id="O2" value="144"/>
                <count group_id="O3" value="171"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.29" lower_limit="-6.00" upper_limit="-4.57"/>
                    <measurement group_id="O2" value="-7.93" lower_limit="-8.71" upper_limit="-7.15"/>
                    <measurement group_id="O3" value="-3.91" lower_limit="-4.75" upper_limit="-3.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>The comparison of YOCAS to the health education control is a traditional null hypothesis of no difference with a two-sided alpha.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>The null hypothesis is that the mean change in the outcome measure between the two arms is zero.</non_inferiority_desc>
            <p_value>0.0108</p_value>
            <p_value_desc>The comparison of YOCAS to the health education control is a traditional null hypothesis of no difference with a two-sided alpha. The p-value shown is from the Least Squares Mean (YOCAS - Health Education) generated from the Mixed Model.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-1.57</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.62</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-2.78</ci_lower_limit>
            <ci_upper_limit>-0.36</ci_upper_limit>
            <estimate_desc>The comparison is from the Least Squares Mean difference (YOCAS - Health Education) generated from the Mixed Model.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Change in the ISI Comparing YOCAS and CBT-I (6 Month)</title>
        <description>The Insomnia Severity Index is a validated measure of insomnia. A 5-point Likert scale of 7 questions is used to rate each item (e.g., 0 = no problem; 4 = very severe problem), yielding a total score ranging from 0 to 28 with higher scores indicating higher severity of insomnia. A linear mixed effects ANCOVA will be used to assess the statistical significance of the differences in mean change between YOCAS and CBT-I.</description>
        <time_frame>Baseline to 6 months</time_frame>
        <population>The overall number of participants analyzed is lower than the number of participants who completed the study. This difference is due to participant non-compliance.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm I (Behavioral Intervention-yoga)</title>
            <description>Patients undergo the YOCAS intervention comprising 18 specific physical postures and mindfulness exercises focused on breathing and meditation and meet with the yoga instructor over 75 minutes 2 times a week for 4 weeks.&#xD;
Behavioral Intervention: Undergo yoga intervention&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
          <group group_id="O2">
            <title>Arm II (Cognitive Intervention-CBT-I)</title>
            <description>Patients undergo CBT-I intervention comprising sleep education, sleep hygiene, sleep restriction, stimulus control, cognitive therapy, and relapse prevention delivered by a health professional over 90 minutes once a week for 8 weeks.&#xD;
Cognitive Intervention: Undergo CBT-I intervention&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
          <group group_id="O3">
            <title>Arm III (Educational Intervention)</title>
            <description>Patients attend survivorship health education sessions over 75 minutes 2 times a week for 4 weeks based on the American Society of Clinical Oncology cancer survivorship educational recommendations delivered by a community health educator. Patients also receive a booklet entitled, &quot;Cancer Survivorship Next Steps for Patients and Their Families.&quot;&#xD;
Educational Intervention: Receive health education&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Change in the ISI Comparing YOCAS and CBT-I (6 Month)</title>
          <description>The Insomnia Severity Index is a validated measure of insomnia. A 5-point Likert scale of 7 questions is used to rate each item (e.g., 0 = no problem; 4 = very severe problem), yielding a total score ranging from 0 to 28 with higher scores indicating higher severity of insomnia. A linear mixed effects ANCOVA will be used to assess the statistical significance of the differences in mean change between YOCAS and CBT-I.</description>
          <population>The overall number of participants analyzed is lower than the number of participants who completed the study. This difference is due to participant non-compliance.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="182"/>
                <count group_id="O2" value="144"/>
                <count group_id="O3" value="171"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.29" lower_limit="-6.0" upper_limit="-4.57"/>
                    <measurement group_id="O2" value="-7.93" lower_limit="-8.71" upper_limit="-7.15"/>
                    <measurement group_id="O3" value="-3.91" lower_limit="-4.75" upper_limit="-3.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The comparison of YOCAS to CBT-I is a traditional null hypothesis of no difference with a two-sided alpha.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>The null hypothesis is that the mean change in the outcome measure between the two arms is zero.</non_inferiority_desc>
            <p_value>&lt;.0001</p_value>
            <p_value_desc>The comparison of YOCAS to CBT-I is a traditional null hypothesis of no difference with a two-sided alpha. The p-value shown is from the Least Squares Mean (YOCAS - CBT-I) generated from the Mixed Model.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>2.78</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.63</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.54</ci_lower_limit>
            <ci_upper_limit>4.02</ci_upper_limit>
            <estimate_desc>The comparison is from the Least Squares Mean difference (YOCAS - CBT-I) generated from the Mixed Model.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 year and 9 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Arm I (Behavioral Intervention-yoga)</title>
          <description>Patients undergo the YOCAS intervention comprising 18 specific physical postures and mindfulness exercises focused on breathing and meditation and meet with the yoga instructor over 75 minutes 2 times a week for 4 weeks.&#xD;
Behavioral Intervention: Undergo yoga intervention&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
        </group>
        <group group_id="E2">
          <title>Arm II (Cognitive Intervention-CBT-I)</title>
          <description>Patients undergo CBT-I intervention comprising sleep education, sleep hygiene, sleep restriction, stimulus control, cognitive therapy, and relapse prevention delivered by a health professional over 90 minutes once a week for 8 weeks.&#xD;
Cognitive Intervention: Undergo CBT-I intervention&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
        </group>
        <group group_id="E3">
          <title>Arm III (Educational Intervention)</title>
          <description>Patients attend survivorship health education sessions over 75 minutes 2 times a week for 4 weeks based on the American Society of Clinical Oncology cancer survivorship educational recommendations delivered by a community health educator. Patients also receive a booklet entitled, &quot;Cancer Survivorship Next Steps for Patients and Their Families.&quot;&#xD;
Educational Intervention: Receive health education&#xD;
Laboratory Biomarker Analysis: Correlative studies&#xD;
Monitoring Device: Correlative studies&#xD;
Quality-of-Life Assessment: Ancillary studies</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="238"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="251"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="251"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="238"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="251"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Hepatic Encephalopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="238"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="251"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Stroke</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="251"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="238"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="251"/>
              </event>
              <event>
                <sub_title>Intracranial hemorrhage/brain met</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="251"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="238"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="251"/>
              </event>
              <event>
                <sub_title>Intraparenchymal hemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="238"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="251"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Confusion/brain met</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="251"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="238"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="251"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="251"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="238"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="251"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acute respiratory distress</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="238"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="251"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="251"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="238"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="251"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Karen Mustian, Study PI</name_or_title>
      <organization>University of Rochester Medical Center</organization>
      <phone>585-275-0557</phone>
      <email>karen_mustian@urmc.rochester.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

